Mark J. Caulfield

Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial—Lipid Lowering Arm (ASCOT-LLA): a multicentre randomised controlled trial

Peter Sever, Björn Dahlöf, Neil R Poulter et al. · The Lancet · 2003 · 3.8K citations

Thrombosis, Hypertension, Cardiovascular Disease +12

Effects of Torcetrapib in Patients at High Risk for Coronary Events

Philip J. Barter, Mark J. Caulfield, Mats Eriksson et al. · New England Journal of Medicine · 2007 · 3.1K citations · Full text

Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-BPLA): a multicentre randomised controlled trial

Björn Dahlöf, Peter Sever, Neil R Poulter et al. · The Lancet · 2005 · 2.9K citations

Hypertension, Cardiovascular Disease, Amlodipine Adding Perindopril +11

Hundreds of variants clustered in genomic loci and biological pathways affect human height

Hana Lango Allen, Karol Estrada, Guillaume Lettre et al. · Nature · 2010 · 2K citations · Full text

Genome-wide Association Study, Genetic Analysis, Allelic Variant +13

Reappraisal of European guidelines on hypertension management: a European Society of Hypertension Task Force document

Giuseppe Mancia, Stéphane Laurent, Enrico Agabiti‐Rosei et al. · Journal of Hypertension · 2009 · 1.7K citations